Posts for the 'Plavix' Category

New research indicates that heart patients who are given Plavix after receiving a stent or having a heart attack, could have an increased risk of death or a new heart attack within 90 days after they stop taking the drug. The information new could alter the way doctors prescribe Plavix to millions of people.

>>INFORMATION: Plavix Side Effects

Read the rest of this entry »

Drug coated heart stents have been linked to an increased risk of serious and potentially fatal blood clots which could develop years after the stent is implanted.  However, there are many individuals who have not experienced a blood clot, heart attack or reclogging of the artery, yet now must remain on Plavix long term after the stent placement.  The Saiontz, Kirk & Miles, P.A. heart stent lawyers are reviewing potential legal claims on behalf of individuals who must remain on Plavix indefintely, as well a those who suffered a heart attack or reclogging of the artery.

>>INFORMATION: Heart Stent Lawsuits

Read the rest of this entry »

In recent television advertisements, Plavix side effects are minimized while viewers are led to believe that they must take the drug to avoid a potentially fatal blood clot.  Individuals who fear a heart attack are encouraged to seek out the medication from their doctor, even if they do not fit the profile for which the medication was approved by the FDA. Read the rest of this entry »

Following the meeting of an FDA panel of experts last week, it does not appear that there will be a drug coated stent recall or removal from the market.  However, medical experts have still indicated that there are serious safety concerns associated with drug eluting stents.  Most patients currently receiving the stents face an increased risk of blood clots, which could lead to heart attacks or death. Read the rest of this entry »

An FDA panel of experts is expected to meet this week to review the drug eluting stent problems, which have generated a lot of concern in the medical community. They will evaluate the drug coated stent blood clot risk, and make recommendations to the FDA about what should be done to protect consumers. Read the rest of this entry »

One of the less common, but certainly very serious, Plavix side effects is the increased risk of TTP (thrombotic thrombocytopenic purpura).  TTP is a rare blood condition which can be fatal.  The manufacturers of Plavix did not adequately and fully warn of this potential side effect which could occur after taking the blood thinner. Read the rest of this entry »

Recently serious questions have been raised about the safety of medicated stents, which are widely used during angioplasty proceedures following heart attacks.  Cardiologists have expressed concerns about medicated stent side effects which may increase risk of heart attacks and blood clots for years after the proceedure. Read the rest of this entry »

Plavix was approved in April 1997 after a rare priority regulatory review by the FDA.  The expedited review was requested so that the medication could be brought to the market very quickly.  When FDA advisory panel recommended that the agency approve the drug, reservations were expressed by some panel members about the benefits of Plavix.  Read the rest of this entry »

Since Saiontz, Kirk & Miles began investigating potential lawsuits for Plavix side effects, we have been contacted by many concerned individuals who used the blood thinner.  In response to several requests for further information regarding the problems with Plavix, we have added more resources to our website about the Plavix claims. Read the rest of this entry »

On October 30, 2006, one of the first Plavix lawsuits was filed in the United States District Court for the District of New Jersey.  Read the rest of this entry »